{
    "2019-10-30": [
        [
            {
                "time": "",
                "original_text": "健帆生物：健帆生物整体经营稳健全年增长可期 买入评级",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "整体经营稳健",
                        "全年增长可期",
                        "买入评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "健帆生物前三季度营收同比增近四成",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "前三季度",
                        "营收同比增",
                        "四成"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}